News

Owens & Minor Names Chief Operating Officer

Owens & Minor, a global healthcare solutions company providing essential products, services and technology solutions that support care delivery in leading hospitals, health systems and research centers around the world, today announced Marc Rottink as Chief Operating Officer (COO) of Owens & Minor, effective immediately.

Rottink brings almost three decades of experience in leading global, multi-site healthcare supply chain operations, including strategic transformation, oversight and management of global inventory assets and distribution operations, integrated business planning, systems implementation, and cross-functional operations alignment. Most recently, Marc served as Senior Vice President of Global Supply Chain and Customer Care for Smith + Nephew. Under his leadership, Smith + Nephew saw significant improvement in its manufacturing operations, as well as sales, inventory, and operational planning (SIOP), greatly enhancing customer fulfillment levels. Prior to Smith + Nephew, Marc served as Vice President of Global Supply Chain for Medtronic’s Restorative Therapies Group.

“In logistics, operational excellence is important, but in healthcare logistics, it’s critical,” said Christian Cook, chairman and interim CEO, Owens & Minor, and managing director at Platinum Equity. “We’re making significant investments in our operations through automation and we’re confident that Marc’s impressive history of successfully leading global operational transformation will be a pivotal asset as Owens & Minor continues to improve the customer experience.”

“Throughout my career, I’ve had great passion for developing and implementing large-scale strategies that help supply chains and product manufacturing operate more efficiently and more responsively,” said Marc Rottink, Chief Operating Officer (COO), Owens & Minor. “I’m more than thrilled to join Owens & Minor and excited for the opportunity to innovate and improve the backbone of our strength—our 140+ years of operational expertise—and take it to the next level.”

On December 31, 2025, Owens & Minor announced a new chapter in its long and storied history: the medical distribution, products and technology services business, formerly referred to as Products & Healthcare Services (P&HS), is now part of the Platinum Equity portfolio. The company continues to operate as a private standalone company under the Owens & Minor name, carrying on the legacy of excellence and service the company has long been known for.

Read more here.

Recent News

11/10/2026

Luminoah Raises $25 Million Series B to Expand Access to Its FDA-Cleared Enteral Feeding System

Luminoah, a medical technology company modernizing enteral nutrition, today announced a $25 million Series B financing led by Sandbox Clinical Ventures, with participation from the Blue Venture Fund, GV (Google Ventures), Sands Capital, Texas Medical Center Venture Fund, the CU Healthcare Innovation Fund, the American Gastroenterological Association GI Opportunity Fund, and existing investors. The Series …

11/04/2026

$6 Million in Philanthropic Gifts Establishes UVA Biotech Innovation Fund

The University of Virginia Paul and Diane Manning Institute of Biotechnology received gifts totaling $6 million from philanthropists to establish the UVA Biotech Innovation Fund. This fund will provide long-term support for the UVA SPARK Innovative Medicines program, helping accelerate promising discoveries toward new treatments and cures. “The mission of the UVA Manning Institute of …

10/29/2026

ReAlta Life Sciences Launches KnowHIE, a New Online Educational Resource for Families of Babies Diagnosed with Hypoxic Ischemic Encephalopathy (HIE)

ReAlta Life Sciences Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to potentially revolutionize the treatment of inflammatory disorders, today announced the launch of KnowHIE.com, a new educational website designed to help families and caregivers better understand neonatal hypoxic ischemic encephalopathy (HIE) …